Comerica Bank Enanta Pharmaceuticals Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.08 - $17.46 $3,356 - $5,814	333 New	333 $5,000
Q3 2023 Nov 21, 2023	SELL	$11.09 - $22.13 $7,873 - $15,712	-710 Reduced 90.45%	75 $0
Q2 2023 Aug 22, 2023	SELL	$20.68 - $39.85 $205,703 - $396,387	-9,947 Reduced 92.69%	785 $0
Q4 2022 Jan 26, 2023	SELL	$40.77 - $53.73 $136,987 - $180,532	-3,360 Reduced 23.84%	10,732 $0
Q3 2022 Oct 28, 2022	SELL	$48.29 - $71.27 $35,251 - $52,027	-730 Reduced 4.93%	14,092 $641,000
Q2 2022 Aug 02, 2022	SELL	$38.13 - $76.93 $24,365 - $49,158	-639 Reduced 4.13%	14,822 $755,000
Q1 2022 Apr 27, 2022	BUY	$56.06 - $74.11 $24,946 - $32,978	445 Added 2.96%	15,461 $1.1 Million
Q4 2021 Feb 18, 2022	SELL	$60.19 - $97.37 $77,946 - $126,094	-1,295 Reduced 7.94%	15,016 $1.12 Million
Q3 2021 Nov 22, 2021	SELL	$41.02 - $58.65 $22,314 - $31,905	-544 Reduced 3.23%	16,311 $926,000
Q2 2021 Aug 26, 2021	SELL	$43.76 - $53.11 $57,719 - $70,052	-1,319 Reduced 7.26%	16,855 $741,000
Q1 2021 Apr 28, 2021	SELL	$41.69 - $54.95 $26,848 - $35,387	-644 Reduced 3.42%	18,174 $896,000
Q4 2020 Jan 28, 2021	BUY	$41.16 - $47.47 $3,333 - $3,845	81 Added 0.43%	18,818 $792,000
Q3 2020 Oct 30, 2020	BUY	$43.36 - $53.53 $66,427 - $82,007	1,532 Added 8.9%	18,737 $857,000
Q2 2020 Jul 31, 2020	BUY	$46.37 - $57.58 $71,780 - $89,133	1,548 Added 9.89%	17,205 $863,000
Q1 2020 May 01, 2020	BUY	$40.22 - $62.0 $25,057 - $38,626	623 Added 4.14%	15,657 $805,000
Q4 2019 Feb 07, 2020	BUY	$57.95 - $66.61 $231 - $266	4 Added 0.03%	15,034 $928,000
Q3 2019 Oct 31, 2019	BUY	$60.08 - $88.17 $6,428 - $9,434	107 Added 0.72%	15,030 $903,000
Q2 2019 Aug 02, 2019	SELL	$81.3 - $97.35 $56,097 - $67,171	-690 Reduced 4.42%	14,923 $0
Q1 2019 May 02, 2019	BUY	$69.08 - $105.66 $19,549 - $29,901	283 Added 1.85%	15,613 $0
Q4 2018 Feb 06, 2019	BUY	$65.41 - $84.65 $5,101 - $6,602	78 Added 0.51%	15,330 $1.18 Million
Q3 2018 Nov 01, 2018	SELL	$85.46 - $126.37 $7,435 - $10,994	-87 Reduced 0.57%	15,252 $1.18 Million
Q2 2018 Aug 01, 2018	BUY	$81.85 - $120.51 $16,206 - $23,860	198 Added 1.31%	15,339 $1.9 Million
Q1 2018 May 01, 2018	BUY	$57.91 - $92.15 $25,248 - $40,177	436 Added 2.96%	15,141 $1.31 Million
Q4 2017 Feb 02, 2018	SELL	$45.65 - $59.37 $17,438 - $22,679	-382 Reduced 2.53%	14,705 $1.06 Million
Q3 2017 Nov 06, 2017	BUY	$37.91 - $46.8 $571,948 - $706,071	15,087	15,087 $748,000

Others Institutions Holding ENTA

# of Institutions

107

Shares Held

21.2M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$10.3 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$9.71 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.05 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.34 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.4 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $102M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account